Ipsen’s Guillaume Freneuil gives his take on the importance of the Algerian market to the global group.
If we are investing right now in Algeria it is because we envisage further growth here to be able to serve patient needs
Guillaume Freneuil – Vice President Intercontinental Operations, Consumer Healthcare Division, Ipsen
02.02.2019
Ipsen’s Guillaume Freneuil gives his take on the importance of the Algerian market to the global group.
Related Interviews
Adlane Soudani – General Manager, Ipsen Algeria
Adlane Soudani, general manager of Ipsen’s Algerian affiliate, lifts the lid on Ipsen’s ambitions for the local market, and the company’s parallel strategies to ramp up local production while simultaneously…
Mehdi Ferdjioui – General Manager North West Africa, GE Healthcare,…
Mehdi Ferdjioui, GM for North West Africa at GE Healthcare explains the importance of his region to the global group and how GE’s innovative medtech solutions plug into helping solve…
Moncef Meklati – General Manager North West Africa, Merck, Algeria
Moncef Meklati, Merck’s general manager for North West Africa, discusses the company’s ambitions in the region, the key to successful joint ventures and evolving attitudes to chronic diseases in Algeria.…
Middle East & Africa / Pharma News Roundup September 2020
A roundup of the latest news from pharma in the Middle East and Africa including China’s announcement that it will be prioritising Africa for access to its COVID-19 vaccine, UAE…
Opinion / The Case for an Algerian FDA in the Wake of Unethical TV Ads
In the wake of a spate of television advertisements for dietary supplements claiming to offer solutions to the COVID-19 crisis, regular PharmaBoardroom contributor Yacine Sellam argues for the need for…
News Roundup / Algeria Pharma July 2020
Below we present recent news from Algeria’s pharmaceutical industry, including the creation of a dedicated Ministry to boost the sector, changes to the advertising rules for dietary supplements, and local…
Latest Report
